AC
IDXX icon

AlphaCore Capital’s Idexx Laboratories IDXX Stock Holding History

AlphaCore Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
2,066
+554
+37% +$311K 0.02% 441
2026
Q1 		$850K Buy
1,512
+1,169
+341% +$750K 0.02% 422
2025
Q4 		$232K Buy
+343
New +$234K 0.01% 919
2020
Q2 		– Sell
-77
Closed -$19K – 183
2020
Q1 		$19K Buy
+77
New +$20.1K 0.01% 165

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

AlphaCore Capital's IDXX Position: Q2 2026 in Review

AlphaCore Capital increased its Idexx Laboratories (IDXX) stake by 37% in Q2 2026, buying an estimated $311K and bringing the position to 2,066 shares worth $1.09M. The position accounts for 0.02% of the portfolio, ranked #441.

AlphaCore Capital first reported a position in IDXX in Q1 2020 and has held it in 4 quarters since. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • AlphaCore Capital held 2,066 shares of Idexx Laboratories worth $1.09M as of Q2 2026.
  • AlphaCore Capital bought 554 Idexx Laboratories shares in Q2 2026, an estimated $311K.
  • Idexx Laboratories made up 0.02% of AlphaCore Capital's portfolio in Q2 2026, its #441 holding.
  • AlphaCore Capital first reported a position in Idexx Laboratories in Q1 2020 and has held it in 4 quarters since.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.